雲白國際有限公司 YNBY International Limited (Incorporated in Bermuda with limited liability) （於百慕達註冊成立之有限公司） （Stock Code 股份代號：30） N O T I F I C AT I O N L E T T E R 通 知 信 函 Dear non-registered shareholders, 15 September 2025 YNBY International Limited (the "Company") – Notice of Publication of Interim Report (the "Current Corporate Communications") The Current Corporate Communications of the Company have been published in English and Chinese languages and are available on the website of The Stock Exchange of Hong K ...

雲白國際有限公司 YNBY International Limited (Incorporated in Bermuda with limited liability) （於百慕達註冊成立之有限公司） （Stock Code 股份代號：30） N O T I F I C AT I O N L E T T E R 通 知 信 函 Dear registered shareholders, YNBY International Limited (the "Company") –Notice of Publication of Interim Report (the "Current Corporate Communications") The Current Corporate Communications of the Company have been published in English and Chinese languages and are available on the website of The Stock Exchange of Hong Kong Limited ("HKEX") at ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 雲白國際有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00030 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | 本月底法定/註冊股本總額： HKD 200,0 ...

Group 1 - The core viewpoint of the article is that Yunbai International (00030.HK) reported an increase in revenue and profit for the six months ending June 30, 2025, compared to the same period last year [1] - The company's revenue for the period was HKD 396 million, up from HKD 362 million in the previous year, indicating a growth of approximately 9.4% [1] - The profit attributable to the owners of the company for the period was HKD 2.37 million, an increase from HKD 1.41 million in the same period last year, reflecting a growth of approximately 68.8% [1]

Core Viewpoint - Yunbai International (00030) reported a mid-year performance for 2025, showing a revenue of approximately HKD 396 million, representing a year-on-year growth of 9.42% [1] - The net profit reached approximately HKD 2.3732 million, reflecting a significant year-on-year increase of 68.51% [1] - The basic earnings per share stood at 0.034 HKD [1] Financial Performance - Revenue for the period was approximately HKD 396 million, which is a 9.42% increase compared to the previous year [1] - Net profit was approximately HKD 2.3732 million, marking a 68.51% growth year-on-year [1] - Basic earnings per share were reported at 0.034 HKD [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00030 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.01 | HKD | | 200,000,000 | 本月底法定/註冊股本總額： HKD 200,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 | ...

Group 1 - Company Yunbai International (00030.HK) announced a board meeting scheduled for August 15, 2025, at 10:30 AM [1] - The meeting will consider and approve the group's unaudited interim results for the six months ending June 30, 2025 [1] - The company will also discuss the potential declaration of dividends, if any [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不對因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 雲白國際有限公司（「本公司」）董事會（「董事會」）宣佈，將於二零二五年八月 十五日（星期五）上午十時三十分假座香港鰂魚涌英皇道979號太古坊康橋大廈32 樓舉行董事會會議，藉以（其中包括）考慮及批准本公司及其附屬公司（「本集團」） 截至二零二五年六月三十日止六個月之未經審核中期業績以及於香港聯合交易所 有限公司及本公司之網站刊發相關業績公佈，以及考慮派付股息（如有）。 承董事會命 雲白國際有限公司 執行董事兼行政總裁 湯明 香港，二零二五年七月三十一日 於本公佈日期，執行董事為董明先生（主席）、湯明先生（行政總裁）及劉懷宇先生； 非執行董事為何濤先生及黃斌先生；及獨立非執行董事為黃顯榮先生、于常海博 士及彭慧冰博士。 雲白國際有限公司 YNBY International Limited （股份代號：00030） （於百慕達註冊成立之有限公司） 董事會會議通告 ...

Core Viewpoint - The article highlights significant movements in the Hong Kong and US stock markets, focusing on various companies' performances and the impact of regulatory changes on specific sectors. Group 1: Hong Kong Stock Market Highlights - Haitian Flavoring (03288) debuted with over a 3% increase, raising HKD 10 billion and holding a 6.2% global market share in soy sauce, leading the Chinese seasoning market with a 4.8% share [1] - Stablecoin concept stocks surged, with Lianlian Digital up 11%, Yika up 9%, and Zhong An Online up 8%, driven by the implementation of Hong Kong's stablecoin regulations [1] - Hezhima Intelligent (02533) rose over 3% as it plans to acquire an AI chip company to expand its automotive and edge AI product lines [1] - Delin Holdings (01709) increased over 3% with an expected annual profit growth of 10%-30% (to HKD 110-130 million) and its subsidiary Synaptic Technology securing tens of millions in A-round financing [1] - Jingtai Technology (02228) saw over a 4% rise, producing its first clinical candidate drug, PRMT5 inhibitor PE-0260, with clinical trials set to start in the second half of 2025 [1] - Gold stocks collectively fell, with Lingbao Gold and Zhu Feng Gold both down 4%, affected by a pullback in spot gold prices [1] - Innovent Biologics (01801) rose over 4% after obtaining global rights for GlycoT's ADC technology, with positive outlooks for IBI363/343's international potential [1] - Longpan Technology (02465) increased over 6% due to policy support accelerating solid-state battery industrialization, with the Ministry of Industry and Information Technology allocating HKD 6 billion for special research [1] Group 2: Other Notable Movements - Simor International (06969) fell over 5% as shareholder Yiwei Lithium Energy announced a third reduction of 3.5% in its stake, dropping to 27% and losing control [2] - Fubo Group (03738) rose over 4% due to favorable policies for data asset REITs, with the company targeting annual AI business revenue in the million-dollar range [2] - Yadea Holdings (01585) increased over 4% with a projected 55% rise in H1 net profit to HKD 1.6 billion, driven by new national standards enhancing industry concentration [2] - Perfect Medical (01830) fell over 6% as medical beauty consumption shifted to Shenzhen and South Korea, with an expected 35% decline in annual profit [2] - Yunbai International (00030) surged over 15% after acquiring global distribution rights from its parent company Yunnan Baiyao, covering a full range of products including medicines and personal care [2] - Luk Fook Holdings (00590) dropped over 4% due to increased gold hedging losses from rising gold prices and high base effects from last year's acquisition of King of Gold [2] Group 3: US Stock Market Highlights - Brain Regen Technologies (RGC.US) fell over 18% after a 400% increase in the previous two days, as profit-taking occurred; the company focuses on liquid formulations for ADHD and autism [3] - Marvell Technology (MRVL.US) rose over 7% after announcing a collaboration to develop AI power solutions and launching a 2nm custom SRAM chip with leading bandwidth and energy efficiency [3] - Circle (CRCL.US) surged over 33% after the US Senate passed a stablecoin bill, boosting the stock's value by 410% since its listing [3] - The rare earth sector continued to rise, with MP Materials up 4.9% and USA Rare Earth up 5.58%, driven by policy support for strategic resource demand [3] - Wolfspeed (WOLF.US) fell over 30% amid reports of a potential bankruptcy agreement, despite the silicon carbide market projected to reach USD 29 billion by 2030 [3] - Odyssey Marine (OMEX.US) rose over 11% after Trump signed an executive order to expedite deep-sea mining permits, with a 93% increase year-to-date [3] - Huya (HUYA.US) increased over 3% as the "HYPER eSports Carnival" is set to open in Chengdu, boosting platform traffic and commercialization expectations [3] Group 4: Additional Notable Movements - AST SpaceMobile (ASTS.US) rose over 10%, with an 85% increase in June, partnering with Vodafone India to provide satellite connectivity to unconnected areas [4] - Arqit Quantum (ARQQ.US) surged over 22% after being selected for Oracle's defense ecosystem, highlighting the strategic value of quantum encryption technology [4] - Aptevo (APVO.US) skyrocketed over 81% due to a new leukemia drug showing an 85% response rate in frontline treatment [4] - Upstart (UPST.US) rose over 10% after Bank of America raised its target price to USD 56, maintaining a "hold" rating as the credit tech platform's valuation recovers [4] - Coinbase (COIN.US) increased over 16% as it plans to apply to the SEC for "tokenized stocks," opening new growth opportunities in traditional equity on-chain [5]

Trading Performance - The group's trading segment recorded revenue of approximately HKD 754.9 million for the fiscal year 2024, an increase of about 32.6% compared to HKD 569.5 million for the nine months ended December 31, 2023[10]. - The trading segment achieved a profit of approximately HKD 54.5 million in fiscal year 2024, up from HKD 41 million in the previous fiscal year[10]. - The e-commerce trading business primarily sells third-party branded products, with significant sales through platforms like Vipshop, JD.com, and Tmall in China[8]. - The group anticipates considerable growth prospects in its trading business, particularly in e-commerce trading, leveraging opportunities in the Chinese market[12]. Market and Economic Context - The Chinese online retail market showed strong growth, with a year-on-year increase of 7.4% to RMB 14.03 trillion from January to November 2024[12]. - The Ministry of Commerce has introduced nine measures to promote stable growth in foreign trade, which is expected to boost confidence in foreign trade development[12]. - The total import and export volume of cross-border e-commerce in China reached RMB 1.88 trillion in the first three quarters of 2024, a year-on-year increase of 11.5%[12]. Financial Overview - General and administrative expenses for FY2024 are approximately HKD 31,000,000, a decrease of about 1.6% from FY2023's HKD 31,500,000[14]. - Other income decreased from approximately HKD 136,000,000 in FY2023 to a loss of about HKD 112,000 in FY2024, primarily due to the absence of gains from the sale of subsidiaries[15]. - Financial expenses for FY2024 were approximately HKD 2,700,000, a reduction of about 22.9% from FY2023's HKD 3,500,000, mainly due to the cessation of interest expenses on convertible bonds[16]. - Income tax expenses increased to approximately HKD 5,800,000 in FY2024 from HKD 2,700,000 in FY2023, primarily due to trading profits from health product raw materials in China[17]. - Basic earnings per share for FY2024 were HKD 0.27, down from HKD 2.11 in FY2023, mainly due to the lack of subsidiary sale gains[18]. - Shareholders' equity increased from approximately HKD 243,200,000 on December 31, 2023, to about HKD 259,900,000 on December 31, 2024[19]. - Cash and cash equivalents as of December 31, 2024, were approximately HKD 212,500,000, up from HKD 199,300,000 on December 31, 2023[20]. - The company does not recommend a final dividend for FY2024, compared to zero in FY2023[21]. Corporate Governance - The company has complied with relevant laws and regulations that significantly impact its operations during the fiscal year ending December 31, 2024[51]. - The company has adopted the corporate governance code as per the listing rules, ensuring compliance and high standards of governance to enhance corporate value and accountability[118]. - The board consists of eight members, including three independent non-executive directors, ensuring a diverse range of professional backgrounds and expertise[123]. - The company has established a shareholder communication policy to ensure effective dialogue with shareholders, including annual reports and regular updates from senior management[162]. - The company has established procedures for directors to seek independent professional advice, with costs covered by the company[122]. Risk Management and Internal Controls - The company has implemented a risk management and internal control system to ensure effective governance and oversight[133]. - The board is responsible for overseeing the risk management and internal control systems, including ESG risks, and has established a three-tier risk management approach[152]. - The audit committee is responsible for reviewing the financial statements and management letters for the year ending December 31, 2024[150]. - An independent internal control consultant was hired to assess the overall internal control of the group, with no significant deficiencies reported[154]. Environmental, Social, and Governance (ESG) Initiatives - The ESG report for the year ending December 31, 2024, aims to enhance stakeholder understanding of the company's operational and ESG developments[171]. - The company adheres to principles of materiality, quantification, balance, and consistency in its ESG reporting[173]. - The company aims to maintain a healthy and safe work environment, implement fair promotion mechanisms, and provide career development opportunities for employees[182]. - The company is committed to sustainable development and has set environmental goals to minimize resource waste, including water and paper[189]. - The total greenhouse gas emissions for the year 2024 amounted to 55.48 tons of CO2 equivalent, with direct emissions at 14.96 tons, indirect emissions at 22.55 tons, and other indirect emissions at 17.97 tons[194]. Leadership and Management - The company has a strong leadership team with diverse backgrounds in international business development, marketing, and technology, enhancing its strategic capabilities[103]. - The company is actively reviewing its organizational structure to align with its corporate strategy, indicating a proactive approach to management[114]. - The company has appointed new independent non-executive directors effective from November 21, 2023, enhancing its governance structure[112][113]. - The company has established a high-level management team to oversee its operations, reflecting a commitment to effective leadership[114]. Employee and Compensation Matters - The total employee compensation for the fiscal year 2024 is approximately HKD 17,200,000, an increase from HKD 14,700,000 in fiscal year 2023[38]. - The compensation committee reviewed the performance of individual executive directors and senior management to recommend their remuneration for the fiscal year, considering factors such as comparable company salary levels and performance-based pay[138]. - One senior management member received a salary in the range of HKD 1,000,001 to HKD 1,500,000 for the fiscal year ending December 31, 2024[137]. Shareholder and Market Engagement - As of October 29, 2024, the company's public float is approximately 25.5%, which will decrease to about 19.84% if all convertible bond rights are exercised by Yunnan Baiyao Group, failing to meet the minimum public float requirement of 25%[72]. - The company is actively seeking investors to increase its public float but has not yet secured any definitive agreements as of the report date[72]. - The company entered into a framework agreement with Yunnan Baiyao Group on December 13, 2022, for the purchase of product registration, global supply chain integration, and professional support services, which constitutes a continuing connected transaction[74].